JVMCX | VVOSX | JVMCX / VVOSX | |
Total Expense Ratio | 1.85 | 0.69 | 268% |
Annual Report Gross Expense Ratio | 1.86 | 0.69 | 270% |
Fund Existence | 14 years | 8 years | - |
Gain YTD | 11.265 | 8.402 | 134% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.3B | 5.43B | 448% |
Annual Yield % from dividends | 0.00 | 0.62 | - |
Returns for 1 year | 1.22 | 16.48 | 7% |
Returns for 3 years | 21.25 | 49.93 | 43% |
Returns for 5 years | 48.03 | 119.77 | 40% |
Returns for 10 years | 45.05 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSQTX | 36.60 | 0.15 | +0.41% |
Goldman Sachs Small Cap Value Inv | |||
BRSHX | 14.71 | 0.06 | +0.41% |
MFS Blended Research Small Cap Eq C | |||
NDVCX | 16.56 | 0.03 | +0.18% |
MFS New Discovery Value C | |||
JGTUX | 44.91 | -0.01 | -0.02% |
JPMorgan Growth Advantage R4 | |||
FBPEX | 27.55 | -0.03 | -0.11% |
Cantor Fitzgerald Equity Div Plus Inst |